
Inorganica Chimica Acta p. 244 - 248 (1999)
Update date:2022-08-04
Topics:
Kanematsu, Naohiro
Ebihara, Masahiro
Kawamura, Takashi
Dinuclear iridium(I) complexes with two bridging aminopyridinato ligands, [Ir(μ-L)(COD)]2 (COD=1,5-cyclooctadiene (1): L=2-aminopyridinato (ap) (2): L=2-anilinopyridinato (anp)), were prepared from [Ir(μ-Cl)(COD)]2 and Li+L- in a 24-36% yield. These compounds were characterized by X-ray structure analysis and 1H NMR spectroscopy. Two iridium atoms were bridged by two aminopyridinato ligands and each iridium atom was coordinated by one chelating COD. The coordination sphere of each Ir(I) center, which was formed by two N atoms and two olefinic π bonds, was square planar. IrIr separations in 1 and 2 were 3.0998(6) and 3.0681(3) A, respectively. Cyclic voltammetry of 1 and 2 in n-Bu4NPF6/CH2Cl2 exhibited a chemically reversible oxidation wave at -0.41 and -0.36 V versus Fc+/Fc, respectively. These potentials were lower than those of [Ir(μ-form)(COD)]2 (form=anion of N,N′-di-p-tolylformamidine), [Ir(μ-hp)(COD)]2 (hp=anion of 2-hydroxypyridine), [Ir(μ-mhp)(COD)]2 (mhp=anion of 6-methyl-2-hydroxypyridine) and [Ir(μ-pz)(COD)]2 (pz=anion of pyrazole). Electrolytic one-electron oxidation of 2 gave its stable cationic radical, [Ir(μ-anp)(COD)]2+, of which frozen solution ESR spectrum was rhombic with g1=2.43, g2=2.30 and g3=2.08 and no hyperfine splitting was resolved.
Hangzhou Gangjin Chemical Co.,Ltd.(expird)
Contact:+86-571-85109780
Address:707 Zhejiang Minhang Bldg., No.290 Zhongshan North Road, Hangzhou 310003, China
ShangHai Soyoung Biotechnology Inc
website:http://www.soyoungbio.com
Contact:+86-21-69893009
Address:shanghai
Jiangsu Allyrise Pharmaceutical Co., Ltd.(expird)
Contact:+86-523-86818997
Address:Taizhou,Jiangsu Province,CHINA
ALPHA PHARMACEUTICAL CO,LTD JIANGSU
Contact:+86-527-84829968,+86-527-84829998
Address:suqian city
website:http://www.cheminn.com/
Contact:86-531-67875205
Address:No.9-2,South of Shanda Road, Jinan ,China
Doi:10.1016/S0040-4039(99)01399-4
(1999)Doi:10.1016/S0008-6215(99)00109-3
(1999)Doi:10.1055/s-1999-3603
(1999)Doi:10.1021/jo00833a018
(1970)Doi:10.1039/jr9550001049
(1955)Doi:10.1016/S0968-0896(99)00164-9
(1999)